| Ozanimod: A Review in Ulcerative Colitis | | |
| Practical aspects of the organization of ethical review of clinical trials in the context of the COVID-19 pandemic | | 2022 |
| Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial | Vaccine | 2022 |
| Estetrol/Drospirenone: A Review in Oral Contraception | Drugs | |
| Anifrolumab in systemic lupus erythematosus: a profile of its use | Drugs and Therapy Perspectives | |
| Odevixibat in progressive familial intrahepatic cholestasis: a profile of its use | Drugs and Therapy Perspectives | |
| Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism | Paediatric Drugs | 2022 |
| Tixagevimab + Cilgavimab: First Approval | Drugs | |
| Delafloxacin: A Review in Community-Acquired Pneumonia | Drugs | 2022 |
| Hyperkalaemia in Heart Failure: Consequences for Outcome and Sequencing of Therapy | Current Heart Failure Reports | |
| Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy | Biology | 2022 |
| Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study | Archivos De Bronconeumologia | 2022 |
| Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC | Targeted Oncology | 2022 |
| Safety evaluation of secukinumab in paediatric patients with plaque psoriasis. | Expert Opinion on Drug Safety | 2022 |
| Baricitinib: A Review in Moderate to Severe Atopic Dermatitis. | American Journal of Clinical Dermatology | 2022 |
| Associations of Plasma Fatty Acid Patterns During Pregnancy With Gestational Diabetes Mellitus | Frontiers in Nutrition | 2022 |
| Clinical Utility of β-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations. | Research and Reports in Urology | 2022 |
| Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle. | European Journal of Internal Medicine | 2022 |
| Data_Sheet_1.doc | | 2020 |
| MYL-1402O: A Bevacizumab Biosimilar. | Targeted Oncology | 2021 |
| Immunophenotyping: analytical approaches and role in preclinical development of nanomedicines. | Advanced Drug Delivery Reviews | 2022 |
| Nirmatrelvir Plus Ritonavir: First Approval. | Drugs | 2022 |
| Risdiplam: A Review in Spinal Muscular Atrophy. | CNS Drugs | 2022 |
| Health Technology Assessment to assess value of biomarkers in the decision-making process. | Clinical Chemistry and Laboratory Medicine | 2022 |
| Emerging small molecule antivirals may fit neatly into COVID-19 treatment. | Drugs and Therapy Perspectives | 2022 |
| Ocrelizumab: A Review in Multiple Sclerosis. | Drugs | 2022 |
| Fused Deposition Modeling as a Possible Approach for the Preparation of Orodispersible Tablets. | Pharmaceuticals | 2022 |
| Somatrogon: First Approval. | Drugs | 2022 |
| CLAYS IN COSMETICS AND PERSONAL-CARE PRODUCTS | Clays and Clay Minerals | 2021 |
| Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays. | Clinical and Translational Immunology | 2022 |
| Impact of recommendations on sodium valproate prescription among women with epilepsy: An interrupted time-series study | Epilepsy and Behavior | 2021 |
| Avacopan: First Approval | Drugs | 2021 |
| Subcutaneous vedolizumab in moderately to severely active ulcerative colitis or Crohn’s disease: a profile of its use | Drugs and Therapy Perspectives | 2021 |
| Nusinersen: A Review in 5q Spinal Muscular Atrophy | CNS Drugs | 2021 |
| Off-label use of hydroxychloroquine in COVID-19: analysis of reports of suspected adverse reactions from the Italian National Network of Pharmacovigilance | Journal of Clinical Pharmacology | 2021 |
| Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study | Infection and Drug Resistance | 2021 |
| Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients | European Journal of Hospital Pharmacy | 2020 |
| An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review | International Journal of Molecular Sciences | 2021 |
| The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma | Pediatric Hematology/Oncology and Immunopathology | 2020 |
| Dermatika | | 2020 |
| Ethical and Regulatory Challenges of Emerging Health Technologies | Advances in Human and Social Aspects of Technology Book Series | 2022 |
| Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience | Dermatologic Therapy | 2021 |
| Avatrombopag: A Review in Thrombocytopenia | Drugs | 2021 |
| Evaluation of New Risk-based Regulatory Approach to Classification of GMP Deficiencies (Review) | Drug Development and Registration | 2020 |
| Aripiprazol Nieman Pick Psikozunda en uygun tedavi seçeneği midir ? | Osmangazİ Journal of Medicine | |
| Simultaneous Determination of Penicillin G and Chloramphenicol in Milk by a Magnetic Nanoparticle-Based Fluorescent Immunoassay | Open Biotechnology Journal | 2020 |
| LEVANTAMENTO DOS FITOTERÁPICOS COMERCIALIZADOS EM UMA FARMÁCIA DO MUNICÍPIO DE CERRO LARGO, RS, BRASIL E INFORMAÇÕES TERAPÊUTICAS DAS PRINCIPAIS ESPÉCIES VEGETAIS ATIVAS | Infarma: Pharmaceutical Sciences | 2019 |
| New Insights into the Pharmacology of Dexmedetomidine and Open Issues for Neurosurgical Procedures | Neuromethods | 2020 |
| Regulatory Perspectives on Biopharmaceuticals for Chronic Inflammatory Diseases in North Africa: A Narrative Review | Open Rheumatology Journal | 2019 |
| Consenso sulla diagnostica di laboratorio per i pazienti in trattamento con farmaci anticoagulanti ad azione diretta. Sottoscritto dalla Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET), dalla Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA), dalla Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC) e dalla Società Italiana di Patologia Clinica e Medicina di Laboratorio (SIPMeL) | Rivista Italiana Della Medicina Di Laboratorio | 2019 |
